Published • loading... • Updated
Losing Muscle with Thinners in Menopause: "It's Not as Much as Thought"
Summary by redaccionmedica.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The GLP-1 receptor agonist drugs, present in medicines such as Wegovy, Mounjaro and Ozempic -based on active substances such as semaglutide or tirzepatide-, have become one of the most relevant treatments in recent years for the treatment of obesity and type 2 diabetes. Their use has also begun to spread among women in the perimenopause and menopause stages, a period in which hormonal changes favor a redistribution of body fat and an increased r…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
